High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis

Journal of Thrombosis and Thrombolysis

Volumn 28, Issue 1, 2009, Pages 63-69

  Alyan, Omer ^a   Metin, Fatma ^b   Kacmaz, Fehmi ^b   Ozdemir, Ozcan ^c   Maden, Orhan ^b   Topaloglu, Serkan ^b   Demir, Ahmet Duran ^b   Karahan, Zulkuf ^a   Karadede, Aziz ^a   Ilkay, Erdogan ^b  

^a DICLE UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c Akay Hospital   (Turkey)

Author keywords

High sensitive C Reactive Protein; Mitral stenosis; Wilkins score

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HIGH SENSITIVE C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC RHEUMATIC MITRAL STENOSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; LEFT ATRIAL AREA; LEFT ATRIAL DIAMETER; LEFT ATRIAL SPONTANEOUS ECHO CONTRAST; LEUKOCYTE COUNT; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN WILKINS VALVE SCORE; MITRAL VALVE; MITRAL VALVE AREA; MITRAL VALVE STENOSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATIC FEVER; SYSTOLIC PULMONARY ARTERIAL PRESSURE; THROMBOCYTE VOLUME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; BLOOD PLATELETS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHRONIC DISEASE; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; RHEUMATIC DISEASES; SEVERITY OF ILLNESS INDEX;

EID: 67449095441     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0245-7     Document Type: Article

References (47)

1. Goldstein I, Rebeyrotte P, Parlebas J et al (1968) Isolation from heart valves of glycopeptides which share Immunologic properties with streptococcus haemolyticus group A polysaccharides. Nature 219:866-868
2. Soler-Soler J, Galve E (2000) Worldwide perspective of valve disease. Heart 83:721-725
3. Ridker PM, Glynn RJ, Hennekens CH (1998) C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97:2007-2011
4. Yeun JY, Levine RA, Mantadilok V et al (2000) C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476
5. Haverkate F, Thompson SG, Pyke SD et al (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Europen concerted action in thrombolisis and disabilities angina pectoris study group. Lancet 349:462-466
6. Ridker PM, Cushman M, Stampfer MJ et al (1998) Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425-428
7. Ridker PM, Buring JE, Shih J et al (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731-733
8. Schoen FJ, St. John M (1991) Contemporary pathologic considerations in valvular disease. In: Virmani B, Atkinson JB, Feuoglio JJ (eds) Cardiovascular pathology. Saunders, Philadelphia, pp 334-353
9. Edep ME, Shirani J, Wolf P et al (2000) Matrix matalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 9:281-286
10. Otto CM, Kuusisto J, Reichenback DD et al (1994) Characterization of the early lesion of valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90:844-853
11. Danesh J, Whincup P, Walker M et al (2000) Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ 321:199-204
12. Chiu-Braga YY, Hayashi SY, Schafranski M et al (2006) Further evidence of inflammation in chronic rheumatic valve disease (CRVD): High levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein. Int J Cardiol 109:275-276
13. Gölbasi Z, Ucar O, Keles T et al (2002) Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease evidence of ongoing inflammation. Eur J Heart Fail 4:593-595
14. Krasuski RA, Bush A, Kay JE et al (2003) C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy. Am Heart J 146:1099-1104
15. Yetkin E, Erbay AR, Ileri M et al (2001) Levels of circulating adhesion molecules in rheumatic mitral stenosis. Am J Cardiol 88:1209-1211
16. Sahn DJ, DeMaria A, Kisslo J et al (1978) Recommendation regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurement. Circulation 58:1072-1083
17. Wilkins GT, Weyman AE, Abascal VM et al (1988) Percutaneous balloon dilatationof the mitral valve. An analysisof echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 60:299-308
18. Hatle L, Angelsen B, Tromsdal A (1979) Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation 60:1096-1104
19. Helmcke F, Nanda NC, Hsiung MC et al (1987) Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 75:175-183
20. Guilherme L, Cunha-neto E, Coelho V et al (1995) Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 92:415-420
21. Stollerman GH (1991) Rheumatologic streptococci and autoimmunity. Clin Immunol Immunopathol 61:131-142
22. Lagrand WK, Visser CA, Hermens WT et al (1999) C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 100:96-102
23. Venugopal SK, Devaraj S, Yuhanna I et al (2002) Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106:1439-1441
24. Venugopal SK, Devaraj S, Jialal I (2003) C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation 108:1676-1678
25. Gerber IL, Stewart RA, Hammett CJ et al (2003) Effect of aortic valve replacement on c-reactive protein in nonrheumatic aortic stenosis. Am J Cardiol 92:1129-1132
26. Buffon A, Liuzzo G, Biasucci LM et al (1999) Preprocedural serum levels of c-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 34:1512-1521
27. Boeken U, Feindt P, Zimmermann N et al (1998) Increased preoperative C-reactive protein values without signs of an infection and complicated course after cardiopulmonary bypass (CPB)-operations. Eur J Cardiothorac Surg 13:541-545
28. Sanchez PL, Santos JL, Kaski JC et al (2006) Grupo AORTICA (Grupo de Estudio de la Estenosis Aortica): Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol 97:90-93
29. Olsson M, Dalsgaard CJ, Haegerstrand A et al (1994) Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 23:1162-1170
30. Mohler ERI, Gannon F, Reynolds C et al (2001) Bone formation and inflammation in cardiac valves. Circulation 103:1522-1528
31. Warrier B, Mallipeddi R, Karla PK et al (2005) The functional role of C-reactive protein in aortic wall calcification. Cardiology 104:57-64
32. Lefer DJ (2002) Statins as potent anti-inflammatory drugs. Circulation 106:2041-2042
33. Rosenson RS, Tangney CC, Casey LC (1999) Inhibition of proinflammatory cytokine production by pravastatin. Lancet 353:983-984
34. Novaro GM, Tiong IY, Pearce GL et al (2001) Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 104:2205-2209
35. Rosenhek R, Rader F, Loho N et al (2004) Statins but not angiotensinconverting enzyme inhibitors delay progression of aortic stenosis. Circulation 110:1291-1295
36. Moura LM, Ramos SF, Zamorano JL et al (2007) Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 49:554-561
37. Bruins P, Velthuis H, Yazdanbakhsh AP et al (1997) Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96:3542-3548
38. Fontes ML, Mathew JP, Rinder HM et al (2005) Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Anesth Analg 101:17-23
39. Hatzinikolaou-Kotsakou EH, Tziakas D, Hotidis A et al (2006) Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am J Cardiol 97:659-661
40. Merino A, Hauptman P, Badimon L et al (1992) Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol 20:1661-1668
41. Black IW, Hopkins AP, Lee LC et al (1991) Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis. J Am Coll Cardiol 18:398-404
42. Bernstein NE, Demopoulos LA, Tunick PA et al (1994) Correlates of spontaneous echo contrast in patients with mitral stenosis and normal sinus rhythm. Am Heart J 128:287-292
43. Goswami KC, Yadav R, Rao MB et al (2000) Clinical and echocardiographic predictors of left atrial clot and spontaneous echo contrast in patients with severe rheumatic mitral stenosis: A prospective study in 200 patients by transesophageal echocardiography. Int J Cardiol 73:273-279
44. Vincelj J, Sokol I, Jaksic O (2002) Prevalence and clinical significance of left atrial spontaneous echo contrast detected by transesophageal echocardiography. Echocardiography 19(4):319-324
45. Yuan YW, Shumg KK (1988) Ultrasonic backscatter from flowing whole blood: II. Dependence on frequency and fibrinogen concentrations. J Acoust Soc Am 84:1195-1200
46. Karthikeyan G, Thachil A, Sharma S et al (2007) Elevated high sensitivity CRP levels in patients with mitral stenosis and left atrial thrombus. Int J Cardiol 122:252-254
47. Ileri M, Buyukasik Y, Ileri NS et al (1998) Activation of blood coagulation in patients with mitral stenosis and sinus ritm. Am J Cardiol 81:795-797